Literature DB >> 27407454

Lipid Profile In Transplant Patients: A Clinical Study.

K V Baliga1, P K Sharma2, M S Prakash3, M Mostafi4.   

Abstract

15 renal transplant recipients were studied for their lipid profile. The patients were on regular post transplant follow up and had non clinical or laboratory evidence of graft dysfunction, intercurrent infection or post transplant diabetes mellitus for at least 3 months prior to the study. The mean duration of transplant was 15 ± 9.5 months (range 3-32 months). Majority (86%) were on triple immunosuppression therapy and received a mean prednisolone dose of 10.5 mg. An equal number of healthy subjects were randomly selected and studied for their lipid profile and served as control for the study group. There was no significant change in the HDL-cholesterol level as compared with controls. However, these patients showed a significantly higher LDL-cholesterol and total cholesterol levels. Further, a significant inverse correlation was observed between triglycerides and total cholesterol levels and transplant duration.

Entities:  

Keywords:  Lipid profile; Renal transplant

Year:  2011        PMID: 27407454      PMCID: PMC4925745          DOI: 10.1016/S0377-1237(03)80101-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  12 in total

1.  Changes in causes of death after renal transplantation, 1966 to 1987.

Authors:  M N Hill; R A Grossman; H I Feldman; S Hurwitz; D C Dafoe
Journal:  Am J Kidney Dis       Date:  1991-05       Impact factor: 8.860

2.  Hyperlipidemia in the nephrotic syndrome.

Authors:  W F Keane; B L Kasiske
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

3.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

4.  Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.

Authors:  J Bagdade; A Casaretto; J Albers
Journal:  J Lab Clin Med       Date:  1976-01

Review 5.  Hyperlipidemia and its management in renal disease.

Authors:  Z A Massy; B L Kasiske
Journal:  Curr Opin Nephrol Hypertens       Date:  1996-03       Impact factor: 2.894

6.  Hyperlipidemia in renal transplant recipients: natural history and response to treatment.

Authors:  C S Ong; C A Pollock; R J Caterson; J F Mahony; D A Waugh; L S Ibels
Journal:  Medicine (Baltimore)       Date:  1994-07       Impact factor: 1.889

7.  Hyperlipidaemia following renal transplantation. A study of the prevalence, 'natural history' and dietary treatment.

Authors:  R Gokal; J I Mann; R A Moore; P J Morris
Journal:  Q J Med       Date:  1979-10

Review 8.  Coronary artery disease in renal transplant recipients.

Authors:  W E Braun; T H Marwick
Journal:  Cleve Clin J Med       Date:  1994 Sep-Oct       Impact factor: 2.321

Review 9.  Dyslipidemia in renal disease.

Authors:  N Mittman; M M Avram
Journal:  Semin Nephrol       Date:  1996-05       Impact factor: 5.299

10.  Oxidation of low density lipoproteins from patients with renal failure or renal transplants.

Authors:  W H Sutherland; R J Walker; M J Ball; S A Stapley; M C Robertson
Journal:  Kidney Int       Date:  1995-07       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.